(Q85041978)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21971766%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

title

Measuring the potency labelling of onabotulinumtoxinA (Botox(®)) and incobotulinumtoxinA (Xeomin (®)) in an LD50 assay (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21971766%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

main subject

botulinum toxin type A

1 reference

Dirk Dressler

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21971766%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Gerd Mander

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21971766%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Klaus Fink

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21971766%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

publication date

5 October 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21971766%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neural Transmission

14 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21971766%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

volume

119

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21971766%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21971766%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

page(s)

13-15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21971766%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00702-011-0719-1

14 February 2020

exact match

0 references

cites work

Dose standardisation of botulinum toxin

1 reference

12 December 2020

Dose standardisation of botulinum toxin

1 reference

12 December 2020

Potency evaluation of a formulated drug product containing 150-kd botulinum neurotoxin type A

1 reference

12 December 2020

Respective potencies of Botox and Dysport: a double blind, randomised, crossover study in cervical dystonia.

1 reference

12 December 2020

Botulinum toxin: dangerous terminology errors.

1 reference

12 December 2020

Experimental conditions substantially influence botulinum toxin potency testing

1 reference

12 December 2020

A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia.

1 reference

12 December 2020

Comparing Botox and Xeomin for axillar hyperhidrosis

1 reference

12 December 2020

Potency equivalence of botulinum toxin preparations

1 reference

12 December 2020

Routine use of Xeomin in patients previously treated with Botox: long term results

1 reference

12 December 2020

The medical geography of air pollution

1 reference

12 December 2020

Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm

1 reference

12 December 2020

Therapeutic botulinum type A toxin: factors affecting potency.

1 reference

12 December 2020